The cardiovascular and cardiac actions of ecstasy and its metabolites
- PMID: 20420571
- DOI: 10.2174/138920110791591526
The cardiovascular and cardiac actions of ecstasy and its metabolites
Abstract
The recreational use of 3, 4 methylenedioxymethamphetamine (ecstasy or MDMA) has increased dramatically over the past thirty years due to its ability to increase stamina and produce feelings of emotional closeness and wellbeing. In spite of the popular perception that MDMA is a safe drug, there is a large literature documenting that the drug can produce significant neurotoxicity, especially in serotonergic and catecholaminergic systems. There are also experimental and clinical data which document that MDMA can alter cardiovascular function and produce cardiac toxicity, including rhythm disturbances, infarction and sudden death. This manuscript will review the literature documenting the cardiovascular responses elicited by MDMA in humans and experimental animals and will examine the underlying mechanisms mediating these responses. We will also review the available clinical, autopsy and experimental data linking MDMA with cardiac toxicity. Most available data indicate that oxidative stress plays an important role in the cardiotoxic actions of MDMA. Moreover, new data indicates that redox active metabolites of MDMA may play especially important roles in MDMA induced toxicity.
Similar articles
-
Changes in cardiovascular responsiveness and cardiotoxicity elicited during binge administration of Ecstasy.J Pharmacol Exp Ther. 2002 Sep;302(3):898-907. doi: 10.1124/jpet.302.3.898. J Pharmacol Exp Ther. 2002. PMID: 12183645
-
MDMA Induced Cardio-toxicity and Pathological Myocardial Effects: A Systematic Review of Experimental Data and Autopsy Findings.Cardiovasc Toxicol. 2019 Dec;19(6):493-499. doi: 10.1007/s12012-019-09526-9. Cardiovasc Toxicol. 2019. PMID: 31073690
-
(+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studies.Neuropsychobiology. 2000;42(1):11-6. doi: 10.1159/000026665. Neuropsychobiology. 2000. PMID: 10867551 Review.
-
Neurotoxicity mechanisms of thioether ecstasy metabolites.Neuroscience. 2007 Jun 8;146(4):1743-57. doi: 10.1016/j.neuroscience.2007.03.028. Epub 2007 Apr 30. Neuroscience. 2007. PMID: 17467183
-
MDMA toxicity and pathological consequences: a review about experimental data and autopsy findings.Curr Pharm Biotechnol. 2010 Aug;11(5):500-9. doi: 10.2174/138920110791591481. Curr Pharm Biotechnol. 2010. PMID: 20420577 Review.
Cited by
-
Psychoactive substance use among students: A cross-sectional analysis.Fundam Clin Pharmacol. 2022 Oct;36(5):908-914. doi: 10.1111/fcp.12771. Epub 2022 Mar 4. Fundam Clin Pharmacol. 2022. PMID: 35194825 Free PMC article.
-
Binge Ethanol and MDMA Combination Exacerbates Toxic Cardiac Effects by Inducing Cellular Stress.PLoS One. 2015 Oct 28;10(10):e0141502. doi: 10.1371/journal.pone.0141502. eCollection 2015. PLoS One. 2015. PMID: 26509576 Free PMC article.
-
Distribution of temperature changes and neurovascular coupling in rat brain following 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") exposure.NMR Biomed. 2015 Oct;28(10):1257-66. doi: 10.1002/nbm.3375. Epub 2015 Aug 19. NMR Biomed. 2015. PMID: 26286889 Free PMC article.
-
3,4-methylenedioxymethamphetamine (MDMA): current perspectives.Subst Abuse Rehabil. 2013 Nov 21;4:83-99. doi: 10.2147/SAR.S37258. eCollection 2013. Subst Abuse Rehabil. 2013. PMID: 24648791 Free PMC article. Review.
-
Effects of 3,4-methylenedioxymethamphetamine (MDMA) and its main metabolites on cardiovascular function in conscious rats.Br J Pharmacol. 2014 Jan;171(1):83-91. doi: 10.1111/bph.12423. Br J Pharmacol. 2014. PMID: 24328722 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
